Literature DB >> 19718045

The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis.

N Baum1, C Schiene-Fischer, M Frost, M Schumann, K Sabapathy, O Ohlenschläger, F Grosse, B Schlott.   

Abstract

The functional diversity of the tumor suppressor protein p53 is mainly regulated by protein interactions. In this study, we describe a new interaction with the peptidyl-prolyl cis/trans isomerase cyclophilin 18 (Cyp18). The interaction reduced the sequence-specific DNA binding of p53 in vitro, whereas the inhibition of the interaction increased p53-reporter gene activity in vivo. The active site of the folding helper enzyme Cyp18 was directly involved in binding. The proline-rich region (amino acids 64-91) of p53 was most likely responsible for the observed binding because a synthetic peptide comprising amino acids 68-81 of p53 inhibited this interaction, and a p53 variant containing a proline residue at position 72 (p53(P72)) interacted with Cyp18 more effectively than the corresponding p53(R72) variant. Impairment of the Cyp18-p53 interaction induced an accumulation of cells in the G2/M phase of the cell cycle, which was more pronounced when p53(P72) was expressed compared with p53(R72) in an otherwise isogenic cellular background. Moreover, p53-dependent apoptosis was elevated in Cyp18 knockout cells, suggesting an antiapoptotic potential of Cyp18-p53 complexes. Functional in vivo data hint to a possible clinical relevance of the p53-Cyp18 interaction observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19718045     DOI: 10.1038/onc.2009.248

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.

Authors:  S M Fayaz; G K Rajanikant
Journal:  Mol Divers       Date:  2015-07-14       Impact factor: 2.943

2.  p53 is an important regulator of CCL2 gene expression.

Authors:  X Tang; M Asano; A O'Reilly; A Farquhar; Y Yang; S Amar
Journal:  Curr Mol Med       Date:  2012-09       Impact factor: 2.222

3.  Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.

Authors:  Joëlle V F Coumans; David Gau; Anne Poljak; Valerie Wasinger; Partha Roy; Pierre D J Moens
Journal:  OMICS       Date:  2014-12

Review 4.  Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Authors:  Melanie Gerard; Angélique Deleersnijder; Jonas Demeulemeester; Zeger Debyser; Veerle Baekelandt
Journal:  Mol Neurobiol       Date:  2011-05-07       Impact factor: 5.590

Review 5.  Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Authors:  Andrzej Galat; Jacqueline Bua
Journal:  Cell Mol Life Sci       Date:  2010-07-04       Impact factor: 9.261

6.  The cytoplasmic cyclophilin from Azotobacter vinelandii interacts with phosphate acetyltransferase isoforms enhancing their in vitro activity.

Authors:  Maria Dimou; Anastasia Venieraki; Chrysoula Zografou; Panagiotis Katinakis
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

7.  p53 suppresses CCL2-induced subcutaneous tumor xenograft.

Authors:  Xiaoren Tang; Salomon Amar
Journal:  Tumour Biol       Date:  2014-12-11

8.  Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA.

Authors:  W Lu; F Cheng; W Yan; X Li; X Yao; W Song; M Liu; X Shen; H Jiang; J Chen; J Li; J Huang
Journal:  Oncogene       Date:  2017-04-10       Impact factor: 9.867

9.  Thermo-kinetic analysis space expansion for cyclophilin-ligand interactions - identification of a new nonpeptide inhibitor using Biacore™ T200.

Authors:  Martin A Wear; Matthew W Nowicki; Elizabeth A Blackburn; Iain W McNae; Malcolm D Walkinshaw
Journal:  FEBS Open Bio       Date:  2017-02-23       Impact factor: 2.693

10.  UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.

Authors:  Guoyi Wu; Nan Lin; Linan Xu; Bo Liu; Mark A Feitelson
Journal:  BMC Cancer       Date:  2013-03-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.